ICL Group Ltd.

Foreign Filer Report • Jan 18, 2018

6-K 1 dp85293_6k.htm FORM 6-K

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of January, 2018

Field: Rule-Page

Field: /Rule-Page

Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F X Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No X

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

ISRAEL CHEMICALS LTD.

INCORPORATION BY REFERENCE

This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

Field: Page; Sequence: 2

Field: /Page

ISRAEL CHEMICALS LTD.

1. Dismissal of Motion for Discovery and Perusal of Documents regarding the Harmonization Project

Field: Page; Sequence: 3

Field: /Page

Item 1

Dismissal of Motion for Discovery and Perusal of Documents regarding the Harmonization Project

The Company hereby reports that, yesterday (January 17, 2018), the Tel Aviv District Court dismissed the motion for discovery and perusal of documents under Section 198A of the Companies Law, 5759-1999, that was filed by a shareholder of the Company, as part of a preliminary proceeding filed in December 2016 prior to an application for approval of a derivative action pertaining to the manner of management and discontinuation of the Harmonization Project. See our announcement from December 8, 2016 (reference no. 2016-02-087000), The Court further imposed on the applicant payment of the Company's expenses and attorney’s fees in connection with the motion.

Field: Page; Sequence: 4

Field: /Page

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Kobi Altman
Name:	Kobi Altman
Title:	Chief Financial Officer

/s/ Lisa Haimovitz
Name:	Lisa Haimovitz
Title:	Senior Vice President, Global General Counsel and Corporate Secretary

Date: January 18, 2018

Field: Page; Sequence: 5; Options: Last

Field: /Page